I would just add that similarly as Jon alluded to Highwinds as the high yield investment, there are not a tremendous number of other large extremely high yielding investments in the portfolio. It’s not as though we have pursued a broad ball approach of very high-yielding mezz investments versus other very low yielding investments. So, there is relative consistency across the portfolio from a yield perspective overall. I think Jon also alluded to the fact this was a 2013 vintage deal that we had the opportunity to do a handful of add-ons over time. So, a bit of an anomaly for sure and I think not something that portends a trend going forward. You also referenced a 4 point NOI spread. I want to make sure I understand that, because I am not sure you are looking at it correctly. I suspect you might be looking at the 10-Q where we described 9.5% investment yields, which are really just the stated interest rate. So a few things to note there, that actually that’s something you are referencing, it actually excludes, for example, follow-on investments, which excludes our senior credit fund investments. It also excludes other sources of yields, including OID, in that calculation. So, as we look at it and Jon Yoder said this as we look at the recent history, our origination yields on a yield basis, has been more like 10.8% or 10.5% for the last several quarters and in fact if you went back to Q4, actually substantially higher even than that number. So look I think it’s an appropriate question, certainly there is a lot of commentary on the topic. We continue to be pleased with how we are performing in the context of that market environment, finding good transactions that will meet our yield. In fact we are not really changing the asset mix to any discernible degree as well.
Fin O’Shea: Yes. You are correct three was – thank you. But it was just core book, core yield, but I appreciate all the color, of course and then just a couple company specific names, I will ask them both at once and move along, can you just provide an update on NTS, I think that was marked a previous non-accrual maybe if I am wrong. And then can you describe or just give a little more color on the nature of the Bolttech add on, what kind of size or what kind of – how could just the infusion in general that came along there and why didn’t it help, should that have helped the mark, how should we look at that? Thank you.